ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
AbSci Corporation

AbSci Corporation (ABSI)

3.98
-0.39
(-8.92%)
Closed June 15 4:00PM
4.17
0.19
(4.77%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
4.17
Bid
3.87
Ask
8.77
Volume
1,763,719
3.92 Day's Range 4.37
1.1111 52 Week Range 6.72
Market Cap
Previous Close
4.37
Open
4.35
Last Trade
5
@
4.01
Last Trade Time
Financial Volume
$ 7,190,424
VWAP
4.0769
Average Volume (3m)
1,114,973
Shares Outstanding
92,938,477
Dividend Yield
-
PE Ratio
-3.35
Earnings Per Share (EPS)
-1.19
Revenue
5.72M
Net Profit
-110.57M

About AbSci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
AbSci Corporation is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker ABSI. The last closing price for AbSci was $4.37. Over the last year, AbSci shares have traded in a share price range of $ 1.1111 to $ 6.72.

AbSci currently has 92,938,477 shares outstanding. The market capitalization of AbSci is $370.82 million. AbSci has a price to earnings ratio (PE ratio) of -3.35.

AbSci (ABSI) Options Flow Summary

Overall Flow

Bearish

Net Premium

-39k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

ABSI Latest News

Absci to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit

VANCOUVER, Wash. and NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be...

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

VANCOUVER, Wash. and NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.11-2.570093457944.285.23.9213308074.54007162CS
4-0.58-12.21052631584.755.23.9211879624.42918599CS
12-1.13-21.3207547175.36.723.9211149735.01010679CS
261.7270.20408163272.456.722.4513918634.61823491CS
522.43139.6551724141.746.721.11119622803.81650189CS
156-16.83-80.14285714292131.53011.11117057945.11897142CS
260-16.83-80.14285714292131.53011.11117057945.11897142CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 5.96
(338.24%)
70.99M
LRHCLa Rosa Holdings Corporation
$ 1.165
(90.61%)
40.6M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
BRFHBarfresh Food Group Inc
$ 3.03
(38.36%)
247.31k
NNENano Nuclear Energy Inc
$ 9.37
(32.53%)
1.77M
NXLNexalin Technologies Inc
$ 0.89
(-35.52%)
3.93M
INABIN8bio Inc
$ 1.095
(-34.82%)
4.92M
QXOQXO Inc
$ 134.10
(-34.71%)
142.29k
GANXGain Therapeutics Inc
$ 1.24
(-34.39%)
3.09M
KYTXKyverna Therapeutics Inc
$ 9.52
(-34.07%)
4.31M
NVDANVIDIA Corporation
$ 131.88
(1.75%)
309.34M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
KITTNauticus Robotics Inc
$ 0.1921
(19.69%)
165.83M
CRKNCrown Electrokinetics Corporation
$ 0.0582
(-21.35%)
136.77M
SQQQProShares UltraPro Short QQQ
$ 8.43
(-1.29%)
112.46M

ABSI Discussion

View Posts
Monksdream Monksdream 2 weeks ago
ABSI
πŸ‘οΈ0
ANTADOG ANTADOG 1 month ago
5,25~~ ANT
πŸ‘οΈ0
ANTADOG ANTADOG 2 months ago
Hello 5's again, ANT
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 months ago
ALGO POP....GOT OUT HERE!!
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 2 months ago
ABSI..IS NOW A WEEKLY BREAK OUT PLAY
πŸ‘οΈ0
ANTADOG ANTADOG 2 months ago
ABSI cruisin', one of my longterm holds, ANT
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
ABSI new 52 hi
πŸ‘οΈ0
ANTADOG ANTADOG 2 months ago
6,50~~ ANT
πŸ‘οΈ0
ANTADOG ANTADOG 2 months ago
Hello 6 bucks, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 2 months ago
5,71~~ ANT
πŸ‘οΈ0
ANTADOG ANTADOG 2 months ago
Behaves like a lowfloater should, 5,56~~ ANT
πŸ‘οΈ0
ANTADOG ANTADOG 2 months ago
churn above 5 bucks continues, first trial update will heat this one up for sure, had a nice long weekend despite the weather, it's my cold Nordland for a reason lol, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
sweet vol again, 5,69~~ ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
5,54~~ have no doubt about my 2024 stocks, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
Good volume so far, almost 600k shares after 150 minutes of tradin', i'll take it, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
the churn around 5 bucks brought strength, 5,56~~ hod so far, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
Double digit stock eoy or sooner: Initiated IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody
Entered into collaboration with AstraZeneca for up to $247M in deal value, plus royalties

Strengthened balance sheet raising approximately $86M in gross proceeds through underwritten common stock offering
fyi ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
VANCOUVER, Wash. and NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today reported financial and operating results for the fourth quarter and year ended December 31, 2023.

"In 2023, Absci further solidified its leadership in AI-driven biologic drug discovery," said Sean McClain, Founder and CEO. "Our breakthroughs in generative AI drug creation have rapidly translated into a differentiated internal portfolio of potential best-in-class and first-in-class programs. With validating strategic industry partnerships and our recent underwritten public offering, we're poised to further advance our pipeline, enhance our AI capabilities, and expand our partnerships. These efforts reflect our commitment to innovation, promising better biologics for patients, faster."

Recent Highlights

In January, Absci presented positive preclinical data for ABS-101, a potential best-in-class anti-TL1A antibody, which exhibited properties consistent with a potentially superior product profile. Based on further confirmatory studies, Absci selected a development candidate and initiated IND-enabling studies for ABS-101 in February 2024.

Completed an underwritten public offering of common stock raising gross proceeds of approximately $86.4 million. Based on the company's current plans, Absci believes its existing cash and cash equivalents and short-term investments, including the net proceeds from the recent underwritten offering of common stock, will be sufficient to fund its operations into the first half of 2027.

Entered into a collaboration with AstraZeneca to deliver an AI-designed antibody against an oncology target. Under the terms of the collaboration agreement, Absci is entitled to receive an upfront commitment, research and development funding, and milestone payments, collectively totaling up to $247 million, in addition to royalties on product sales.

Entered into a partnership with PrecisionLife, a leading computational biology company driving precision medicine in complex chronic diseases, to develop a joint portfolio of potential therapeutics addressing unmet medical needs.

Appointed Professor Sir Menelas β€œMene” Pangalos to Absci's Board of Directors and as co-chair of Absci’s Scientific Advisory Board. Sir Mene, who has over 25 years of experience in drug discovery and development, is retiring from his position as the Executive Vice President of BioPharmaceuticals R&D at AstraZeneca, and joins Absci as the company scales its AI-enabled portfolio of partnered and wholly-owned asset programs.

check it out, fyi ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
Hello five, toyin' stopped, expectin' the same with my other long holdings, the market is bein' played by kids lol, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
less daily volume and green, are they done toyin'? Hmmm, thx for those 4,60's, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
another toy-and-short day, and, 450k shares traded after less than 2 hours, it's all in the game, ANT
πŸ‘οΈ0
Dennisb68 Dennisb68 3 months ago
Earnings out 3/28 after market close.
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
ABSI 10Q due 3/21
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
these days are just like: "let's take it down and see how much shares we can shake/steal", if u have plenty of dry powder, u just don't mind, for some with little cash, it can be frustratin', personally i don't mind, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
see what i mean? 296,780 shares at 4,88, 16:56:26 afterhours , fyi ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
since there was alot of demand on the stock placement, this is/was an excellent opportunity to buy in for those not lucky last week, i dare to say that even more shares from this lowfloater are in stronger hands now, imvho ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
260k shares traded after 2 hours, double digit stock eoy if not sooner, some results will do the trick, imosho ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
lookin' for another volume intact day, 5,06~~ ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
4,50 x 2 = 9 bucks but i have 8 bucks as my first target, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
5,12~~ ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
5,11~~ ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
5,03~~ ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
4,99~~ ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
Volume almost intact, nice buyin' happenin', ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
4,91~~ ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
4,80~~ If you look down 5 posts, u'll notice just how thin this gem is, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
Chart resettin' for the nxt runup which will crack that 6,40 (just a few days ago, silly market lol), u just got to know when to buy more, think chart, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
more cheapies, keep 'm comin', i'm long absi, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
1 million shares traded, volume intact, fyi ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
added 5,20's, once they get the picture of "long holders", the squeeze could be phenomenal, fyi ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
5,70~~ cruisin' on a Friday, that feelin', ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
5,66~~ ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
almost 500k shares traded after 45 minutes, me likey, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
ask yourself how many shares are locked already, i do think ALOT, and by deep pockets, imosho ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
Six bucks just around the corner, fyi ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
Awesome early volume, a keeper in my book, for sure, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
5,63~~ this puppy is goin' places, 8 bucks is my first target, just fyi ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
5,54~~ ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
Added 5,17's, thx, ANT
πŸ‘οΈ0
ANTADOG ANTADOG 3 months ago
volume of 1 million shares will be met again today, share exchange at a higher level continues, lookin' for 5 bucks base to hold, fyi ANT
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock